{"id":407215,"date":"2021-01-04T06:33:27","date_gmt":"2021-01-04T11:33:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407215"},"modified":"2021-01-04T06:33:27","modified_gmt":"2021-01-04T11:33:27","slug":"emergent-biosolutions-to-participate-in-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/","title":{"rendered":"Emergent BioSolutions to Participate in Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">GAITHERSBURG, Md., Jan.  04, 2021  (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company\u2019s executive management team will participate in the following investor conferences in the first quarter of 2021:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>39th\u00a0Annual\u00a0J.P. Morgan Healthcare Conference <\/strong><br \/>\n          <br \/>January 11 to 14, 2021<br \/>Company presentation scheduled on\u00a0January 11\u00a0at\u00a08:20am EST<\/p>\n<\/li>\n<li>\n          <strong>J.P. Morgan 2021 Global High Yield &amp; Leveraged Finance Conference<\/strong><br \/>\n          <br \/>March 1 to 3, 2021<br \/>Presentation date and time will be updated on the Emergent website as the information becomes available.<\/p>\n<\/li>\n<li>\n          <strong>Cowen 41st Annual\u00a0Health Care Conference<\/strong><br \/>\n          <br \/>March 1 to 4, 2021<br \/>Presentation date and time will be updated on the Emergent website as the information becomes available.<\/li>\n<\/ul>\n<p align=\"left\">For conferences where a presentation is planned, the company\u2019s webcast presentation may include a discussion of the company&#8217;s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V1rXWtD1Rtx3tRDIsDDYknvCgdybdNuPDaqTIr1QsAs8Z0DzXRQAU8bsyvr0R4CXi1dSI1qGzj1jx0FQvpe8uDJANfaTjqESVGsA-d-jUzkkjqTPaTBI3WopBzt2nZ8r\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Emergent website<\/a>.<\/p>\n<p align=\"left\">\n        <strong>About Emergent BioSolutions<\/strong><br \/>\n        <br \/>Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what\u2019s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5EMpuyom0cX4U_sQcLhOR3r78JEHL3iDMxb4KKrDxL_wXjv-GYIEKplqKUSJ5xygVhL5oiLgx2wRKCxaDaZU5g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">website<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PCqtNzq6hk2c_9siKmqWS2naVKtb1B4lPgOmnFklGxpf43Dhix2Dfc6LA70L1OhsNIDQsJKYiCYc0DnTXVk8BbQavMm00M3VwVJbiEDVCprWAlvuqx29L66v552bZ1yS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UKbbdmG1ULW1I9MWvqYeaeqnnRYNQYwzxhCcxwV3N7D1QTBd0_S4OfMwr7LsgBoUuhhJKrK1yWrhUdWjpWV0JA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Twitter<\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kFXLserKUfoKfJCyHLIG9Ov1Nudr1EEevwI_7XmQK3jOKSmkkqIOsTbmj8tu0kY99Xw6g9saGZoN3Zls97rnX3fmXlGWWW5sQQiRCSTICSA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Robert G. Burrows<br \/>Vice President, Investor Relations<br \/>240-631-3280<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YaSALV7aK2z4okBTFtirviZw3t-eyp5icd4IWnbAtgbLbRxiS3GywnJq6swX0g9A6UGZMgZEM7ZfnTq1C8Nenw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">burrowsr@ebsi.com<\/a>\u00a0\u00a0<\/p>\n<p align=\"left\">\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Miko B. Neri<br \/>Senior Director, Global Communications &amp; Public Affairs<br \/>240-631-3392<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-d9H9F_pOmaUrNJe6JvNciN3ZEqRptqLXXaJOqSd10NH95TrzWpPsBmNmxmPyhbngm7pan_jdKbvrBpHWW3QnA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">nerim@ebsi.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/8e3673f8-1161-45e9-8bf6-207e8af26946\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company\u2019s executive management team will participate in the following investor conferences in the first quarter of 2021: 39th\u00a0Annual\u00a0J.P. Morgan Healthcare Conference January 11 to 14, 2021Company presentation scheduled on\u00a0January 11\u00a0at\u00a08:20am EST J.P. Morgan 2021 Global High Yield &amp; Leveraged Finance Conference March 1 to 3, 2021Presentation date and time will be updated on the Emergent website as the information becomes available. Cowen 41st Annual\u00a0Health Care Conference March 1 to 4, 2021Presentation date and time will be updated on the Emergent website as the information becomes available. For conferences where a presentation is planned, the company\u2019s webcast presentation may include a discussion &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Emergent BioSolutions to Participate in Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407215","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Emergent BioSolutions to Participate in Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emergent BioSolutions to Participate in Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company\u2019s executive management team will participate in the following investor conferences in the first quarter of 2021: 39th\u00a0Annual\u00a0J.P. Morgan Healthcare Conference January 11 to 14, 2021Company presentation scheduled on\u00a0January 11\u00a0at\u00a08:20am EST J.P. Morgan 2021 Global High Yield &amp; Leveraged Finance Conference March 1 to 3, 2021Presentation date and time will be updated on the Emergent website as the information becomes available. Cowen 41st Annual\u00a0Health Care Conference March 1 to 4, 2021Presentation date and time will be updated on the Emergent website as the information becomes available. For conferences where a presentation is planned, the company\u2019s webcast presentation may include a discussion &hellip; Continue reading &quot;Emergent BioSolutions to Participate in Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T11:33:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Emergent BioSolutions to Participate in Investor Conferences\",\"datePublished\":\"2021-01-04T11:33:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/\",\"name\":\"Emergent BioSolutions to Participate in Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=\",\"datePublished\":\"2021-01-04T11:33:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-to-participate-in-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emergent BioSolutions to Participate in Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emergent BioSolutions to Participate in Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Emergent BioSolutions to Participate in Investor Conferences - Market Newsdesk","og_description":"GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company\u2019s executive management team will participate in the following investor conferences in the first quarter of 2021: 39th\u00a0Annual\u00a0J.P. Morgan Healthcare Conference January 11 to 14, 2021Company presentation scheduled on\u00a0January 11\u00a0at\u00a08:20am EST J.P. Morgan 2021 Global High Yield &amp; Leveraged Finance Conference March 1 to 3, 2021Presentation date and time will be updated on the Emergent website as the information becomes available. Cowen 41st Annual\u00a0Health Care Conference March 1 to 4, 2021Presentation date and time will be updated on the Emergent website as the information becomes available. For conferences where a presentation is planned, the company\u2019s webcast presentation may include a discussion &hellip; Continue reading \"Emergent BioSolutions to Participate in Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T11:33:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Emergent BioSolutions to Participate in Investor Conferences","datePublished":"2021-01-04T11:33:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/"},"wordCount":289,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/","name":"Emergent BioSolutions to Participate in Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=","datePublished":"2021-01-04T11:33:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExOTcxNyMzOTAyNDE3IzIwMTA4NjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-to-participate-in-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Emergent BioSolutions to Participate in Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407215"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407215\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}